The primary endpoint in the final analysis was assessed by change in the North Star Ambulatory Assessment at one year after treatment
Hearing restoration was observed within 30 days of a single administration of AK-OTOF in the initial AK-OTOF-101 study participant
The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18%) of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
A novel second-generation approach to achieve a safe, durable, and stable transgene expression to overcome the challenges of factor VIII replacement therapies
Agreement builds on previous Novartis success using emerging technologies to develop first-in-class gene therapies for neurological disorders
Subscribe To Our Newsletter & Stay Updated
